Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease

Details for Australian Patent Application No. 2005311769 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Wedel, Mark K.

Agent Wrays

Pub. Number AU-A-2005311769

PCT Pub. Number WO2006/060649

Priority 60/632,826 02.12.04 US; 60/716,355 12.09.05 US

Filing date 2 December 2005

Wipo publication date 8 June 2006

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/060649 Priority application(s): WO2006/060649

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311774-System and software of enhanced pharmacy services and related methods

2005311759-Hydraulic power supply system